Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 575
Filtrar
1.
Bioeng Transl Med ; 8(6): e10573, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38023717

RESUMEN

The cytokine interleukin (IL)-11 has been shown to play a role in promoting fibrosis and cancer, including lung adenocarcinoma, garnering interest as an attractive target for therapeutic intervention. We used combinatorial methods to engineer an IL-11 variant that binds with higher affinity to the IL-11 receptor and stimulates enhanced receptor-mediated cell signaling. Introduction of two additional point mutations ablates IL-11 ligand/receptor association with the gp130 coreceptor signaling complex, resulting in a high-affinity receptor antagonist. Unlike wild-type IL-11, this engineered variant potently blocks IL-11-mediated cell signaling and slows tumor growth in a mouse model of lung cancer. Our approach highlights a strategy where native ligands can be engineered and exploited to create potent receptor antagonists.

2.
Nature ; 623(7986): 366-374, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37914930

RESUMEN

The role of the nervous system in the regulation of cancer is increasingly appreciated. In gliomas, neuronal activity drives tumour progression through paracrine signalling factors such as neuroligin-3 and brain-derived neurotrophic factor1-3 (BDNF), and also through electrophysiologically functional neuron-to-glioma synapses mediated by AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors4,5. The consequent glioma cell membrane depolarization drives tumour proliferation4,6. In the healthy brain, activity-regulated secretion of BDNF promotes adaptive plasticity of synaptic connectivity7,8 and strength9-15. Here we show that malignant synapses exhibit similar plasticity regulated by BDNF. Signalling through the receptor tropomyosin-related kinase B16 (TrkB) to CAMKII, BDNF promotes AMPA receptor trafficking to the glioma cell membrane, resulting in increased amplitude of glutamate-evoked currents in the malignant cells. Linking plasticity of glioma synaptic strength to tumour growth, graded optogenetic control of glioma membrane potential demonstrates that greater depolarizing current amplitude promotes increased glioma proliferation. This potentiation of malignant synaptic strength shares mechanistic features with synaptic plasticity17-22 that contributes to memory and learning in the healthy brain23-26. BDNF-TrkB signalling also regulates the number of neuron-to-glioma synapses. Abrogation of activity-regulated BDNF secretion from the brain microenvironment or loss of glioma TrkB expression robustly inhibits tumour progression. Blocking TrkB genetically or pharmacologically abrogates these effects of BDNF on glioma synapses and substantially prolongs survival in xenograft models of paediatric glioblastoma and diffuse intrinsic pontine glioma. Together, these findings indicate that BDNF-TrkB signalling promotes malignant synaptic plasticity and augments tumour progression.


Asunto(s)
Adaptación Fisiológica , Glioma , Plasticidad Neuronal , Sinapsis , Animales , Niño , Humanos , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina/metabolismo , Proliferación Celular , Progresión de la Enfermedad , Glioma/metabolismo , Glioma/patología , Ácido Glutámico/metabolismo , Neuronas/citología , Neuronas/metabolismo , Receptor trkB/genética , Receptor trkB/metabolismo , Receptores AMPA/metabolismo , Transducción de Señal , Sinapsis/metabolismo , Microambiente Tumoral , Optogenética
3.
Nat Cell Biol ; 25(10): 1506-1519, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37783795

RESUMEN

Brain metastases represent an important clinical problem for patients with small-cell lung cancer (SCLC). However, the mechanisms underlying SCLC growth in the brain remain poorly understood. Here, using intracranial injections in mice and assembloids between SCLC aggregates and human cortical organoids in culture, we found that SCLC cells recruit reactive astrocytes to the tumour microenvironment. This crosstalk between SCLC cells and astrocytes drives the induction of gene expression programmes that are similar to those found during early brain development in neurons and astrocytes. Mechanistically, the brain development factor Reelin, secreted by SCLC cells, recruits astrocytes to brain metastases. These astrocytes in turn promote SCLC growth by secreting neuronal pro-survival factors such as SERPINE1. Thus, SCLC brain metastases grow by co-opting mechanisms involved in reciprocal neuron-astrocyte interactions during brain development. Targeting such developmental programmes activated in this cancer ecosystem may help prevent and treat brain metastases.


Asunto(s)
Neoplasias Encefálicas , Neoplasias Pulmonares , Humanos , Animales , Ratones , Astrocitos/patología , Neoplasias Pulmonares/metabolismo , Ecosistema , Neoplasias Encefálicas/metabolismo , Encéfalo/metabolismo , Microambiente Tumoral
4.
Curr Biol ; 32(17): 3758-3772.e4, 2022 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-35973432

RESUMEN

Sweet and bitter compounds excite different sensory cells and drive opposing behaviors. However, it remains unclear how sweet and bitter tastes are represented by the neural circuits linking sensation to behavior. To investigate this question in Drosophila, we devised trans-Tango(activity), a strategy for calcium imaging of second-order gustatory projection neurons based on trans-Tango, a genetic transsynaptic tracing technique. We found spatial overlap between the projection neuron populations activated by sweet and bitter tastants. The spatial representation of bitter tastants in the projection neurons was consistent, while that of sweet tastants was heterogeneous. Furthermore, we discovered that bitter tastants evoke responses in the gustatory receptor neurons and projection neurons upon both stimulus onset and offset and that bitter offset and sweet onset excite overlapping second-order projections. These findings demonstrate an unexpected complexity in the representation of sweet and bitter tastants by second-order neurons of the gustatory circuit.


Asunto(s)
Proteínas de Drosophila , Gusto , Animales , Drosophila/fisiología , Proteínas de Drosophila/genética , Neuronas/fisiología , Gusto/fisiología , Percepción del Gusto/fisiología
5.
Findings (Syd) ; 20222022.
Artículo en Inglés | MEDLINE | ID: mdl-36755795

RESUMEN

This study evaluates concurrent validity, test-retest reliability, and usability of the Strava smartphone app for measuring bicycling locations in urban and rural field tests. Strava location data were inside an 11-meter buffer on average 64% of the time compared to Qstarz' 52%, over 100 evaluations (n participants=73). Most participants agreed or strongly agreed that the Strava app was useful (83%) and that they would prefer to use a smartphone app to track their bicycling (42%). Results indicate that the Strava app is reliable and valid for measuring bicycling locations in these field tests.

6.
Benef Microbes ; 12(4): 35-43, 2021 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-34169805

RESUMEN

Prebiotics are nondigestible food agents that stimulate the growth of bacteria in the gut, whereas probiotics are live microorganisms that replace or restore beneficial bacteria in the digestive tract. Both agents have been shown to have beneficial qualities within the microbiota-gut-brain axis, but the behavioural effects of prebiotics have been less studied than probiotics. Whereas several studies have shown that prebiotics reduce inflammation and modulate anxiety in animals that are injected with lipopolysacccharides or chronically stressed animals, respectively, it is not yet known how they affect a healthy organism. Here, we tested the behavioural effects of galacto-oligosaccharides and beta glucan as a commercially available prebiotic blend in healthy, naïve Sprague-Dawley rats. We used the open field test and elevated plus maze to assess anxiety-like behaviour in controls and in rats that ingested the prebiotic blend in their drinking water. We also used the Morris Water Maze to assess spatial memory performance in controls and prebiotic treated rats. Rats treated with prebiotics spent more time in the intermediate zone of the open field test and in the open arms of the elevated plus maze, and exhibited a shorter latency to enter each of these zones. No significant differences between groups were found in the Morris Water Maze. Our results suggest that whereas prebiotics significantly reduced anxiety-like behaviours, it had no effect on spatial memory performance. Altogether, our data indicate that commercially available prebiotic beta glucan blends have anxiolytic effects in healthy rats.


Asunto(s)
Ansiolíticos , Oligosacáridos , Prebióticos , beta-Glucanos , Animales , Ansiolíticos/farmacología , Ansiedad/terapia , Oligosacáridos/farmacología , Ratas , Ratas Sprague-Dawley , Memoria Espacial , beta-Glucanos/farmacología
7.
J Intern Med ; 289(1): 97-115, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32613681

RESUMEN

BACKGROUND: SARS-CoV-2 coronavirus infection ranges from asymptomatic through to fatal COVID-19 characterized by a 'cytokine storm' and lung failure. Vitamin D deficiency has been postulated as a determinant of severity. OBJECTIVES: To review the evidence relevant to vitamin D and COVID-19. METHODS: Narrative review. RESULTS: Regression modelling shows that more northerly countries in the Northern Hemisphere are currently (May 2020) showing relatively high COVID-19 mortality, with an estimated 4.4% increase in mortality for each 1 degree latitude north of 28 degrees North (P = 0.031) after adjustment for age of population. This supports a role for ultraviolet B acting via vitamin D synthesis. Factors associated with worse COVID-19 prognosis include old age, ethnicity, male sex, obesity, diabetes and hypertension and these also associate with deficiency of vitamin D or its response. Vitamin D deficiency is also linked to severity of childhood respiratory illness. Experimentally, vitamin D increases the ratio of angiotensin-converting enzyme 2 (ACE2) to ACE, thus increasing angiotensin II hydrolysis and reducing subsequent inflammatory cytokine response to pathogens and lung injury. CONCLUSIONS: Substantial evidence supports a link between vitamin D deficiency and COVID-19 severity but it is all indirect. Community-based placebo-controlled trials of vitamin D supplementation may be difficult. Further evidence could come from study of COVID-19 outcomes in large cohorts with information on prescribing data for vitamin D supplementation or assay of serum unbound 25(OH) vitamin D levels. Meanwhile, vitamin D supplementation should be strongly advised for people likely to be deficient.


Asunto(s)
Enzima Convertidora de Angiotensina 2/metabolismo , COVID-19/etnología , Etnicidad , SARS-CoV-2 , Trombosis/etiología , Deficiencia de Vitamina D/etnología , COVID-19/metabolismo , Comorbilidad , Salud Global , Humanos , Factores de Riesgo , Trombosis/etnología , Trombosis/metabolismo , Deficiencia de Vitamina D/metabolismo
8.
Cancer Cell ; 38(2): 229-246.e13, 2020 08 10.
Artículo en Inglés | MEDLINE | ID: mdl-32707077

RESUMEN

Tumor evolution from a single cell into a malignant, heterogeneous tissue remains poorly understood. Here, we profile single-cell transcriptomes of genetically engineered mouse lung tumors at seven stages, from pre-neoplastic hyperplasia to adenocarcinoma. The diversity of transcriptional states increases over time and is reproducible across tumors and mice. Cancer cells progressively adopt alternate lineage identities, computationally predicted to be mediated through a common transitional, high-plasticity cell state (HPCS). Accordingly, HPCS cells prospectively isolated from mouse tumors and human patient-derived xenografts display high capacity for differentiation and proliferation. The HPCS program is associated with poor survival across human cancers and demonstrates chemoresistance in mice. Our study reveals a central principle underpinning intra-tumoral heterogeneity and motivates therapeutic targeting of the HPCS.


Asunto(s)
Plasticidad de la Célula/genética , Células Epiteliales/metabolismo , Transición Epitelial-Mesenquimal/genética , Neoplasias Pulmonares/genética , Células Madre Neoplásicas/metabolismo , Animales , Diferenciación Celular/genética , Línea Celular Tumoral , Proliferación Celular/genética , Células Cultivadas , Modelos Animales de Enfermedad , Células Epiteliales/citología , Heterogeneidad Genética , Humanos , Neoplasias Pulmonares/patología , Ratones , Análisis de la Célula Individual/métodos , Transcriptoma/genética
9.
Ir Med J ; 113(2): 18, 2020 02 13.
Artículo en Inglés | MEDLINE | ID: mdl-32401003

RESUMEN

Introduction To examine efficacy and tolerability of Levetiracetam monotherapy as a first line agent in a national cohort of children with epilepsy, naïve to anti-epileptic medication. Methods A retrospective analysis of children with epilepsy who attended 4 Irish tertiary Paediatric Neurology Clinics (2009-2015) started on Levetiracetam as a first line monotherapy. Results 182 children were identified aged one month to 16 years (mean 6.2 years (SD=5.1) Retention at 6 and 12 months was 88% (n=161) and 83% (n=145) respectively. 75% (n=104) achieved seizure freedom or > 50% improvement in seizure control at 12 months. 30% (n=55) experienced ≥1 adverse effect with aggression (12%; n=21) the most frequent. Treatment was discontinued in 16% (n=29) because of intolerance. Underlying conditions and epilepsy type were not found to influence efficacy or tolerability. Conclusion Levetiracetam monotherapy was observed as effective and safe for children with epilepsy although side effects limit tolerance in a sizeable minority.


Asunto(s)
Tolerancia a Medicamentos , Epilepsia/tratamiento farmacológico , Levetiracetam/uso terapéutico , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Irlanda , Levetiracetam/efectos adversos , Masculino , Estudios Retrospectivos , Seguridad , Resultado del Tratamiento
11.
Neuron ; 96(4): 783-795.e4, 2017 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-29107518

RESUMEN

Mapping neural circuits across defined synapses is essential for understanding brain function. Here we describe trans-Tango, a technique for anterograde transsynaptic circuit tracing and manipulation. At the core of trans-Tango is a synthetic signaling pathway that is introduced into all neurons in the animal. This pathway converts receptor activation at the cell surface into reporter expression through site-specific proteolysis. Specific labeling is achieved by presenting a tethered ligand at the synapses of genetically defined neurons, thereby activating the pathway in their postsynaptic partners and providing genetic access to these neurons. We first validated trans-Tango in the Drosophila olfactory system and then implemented it in the gustatory system, where projections beyond the first-order receptor neurons are not fully characterized. We identified putative second-order neurons within the sweet circuit that include projection neurons targeting known neuromodulation centers in the brain. These experiments establish trans-Tango as a flexible platform for transsynaptic circuit analysis.


Asunto(s)
Técnicas de Trazados de Vías Neuroanatómicas/métodos , Neuronas/fisiología , Percepción del Gusto/fisiología , Animales , Animales Modificados Genéticamente , Drosophila , Vías Nerviosas/fisiología , Vías Olfatorias/fisiología
13.
Rev Sci Tech ; 33(1): 265-72, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25000799

RESUMEN

The principles of humane experimental technique, first described by Russell and Burch in 1959, focus on minimising suffering to animals used for scientific purposes. Internationally, as these principles became embedded in the various systems of oversight for the use of animals in science, attention focused on how to minimise pain, distress and lasting harm to animals while maximising the benefits to be obtained from the work. Suffering can arise from the experimental procedures, but it can also arise from the manner in which the animals are housed and cared for. Increased attention is therefore being paid to the entire lifetime experience of an animal, in order to afford it as good a quality of life as possible. Russell and Burch were also concerned that animals should not be used if alternatives to such use were available, and that animals were not wasted through poor-quality science. This concept is being revisited through new efforts to ensure that experiments are well designed and properly reported in the literature, that all results--positive, negative or neutral--are made available to ensure a complete research record, and that animal models are properly evaluated through periodic systematic reviews. These efforts should ensure that animal use is truly reduced as far as possible and that the benefits derived through the use of animals truly outweigh the harms.


Asunto(s)
Alternativas a las Pruebas en Animales/métodos , Bienestar del Animal/normas , Derechos del Animal , Animales , Proyectos de Investigación
14.
Lab Anim ; 47(3): 146-52, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23563121

RESUMEN

Replacement, Reduction and Refinement, the 'Three Rs' of Russell & Burch, are accepted worldwide as fundamental to the ethics of animal experimentation. The production, care and use of genetically-altered animals can pose particular challenges to the implementation of the Three Rs,1 necessitating additional considerations by those responsible for overseeing the ethical use and appropriate care of animals involved in science. The International Council for Laboratory Animal Science brings representatives of the international laboratory animal science community together to recommend acceptance of guidance documents.The harmonization of guidance concerning genetically-altered animals was seen as a priority because of the increasing globalization of research involving these animals.


Asunto(s)
Bienestar del Animal , Animales Modificados Genéticamente/fisiología , Ciencia de los Animales de Laboratorio , Experimentación Animal/normas , Animales , Ciencia de los Animales de Laboratorio/normas
15.
Plant Dis ; 97(6): 837, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30722642

RESUMEN

Ailanthus altissima (Mill.) Swingle, commonly known as tree-of-heaven, is an invasive tree species that has spread throughout the United States since its introduction in 1784 (2). During a survey in July 2009, approximately 1,100 A. altissima trees were observed at two locations in western Virginia (a roadside in Montgomery Co. and a wooded area adjacent to a railroad in Bedford Co.) exhibiting foliar wilt symptoms, defoliation, yellowish vascular discoloration, or death at an incidence of ~77%. Similar symptoms on A. altissima were reported in Roanoke, VA in the early 1930s and after 2005 in Pennsylvania, attributed to a Verticillium sp. (1,2). To identify the causal agent, discolored xylem tissue samples were excised from 10 symptomatic A. altissima trees at both locations, soaked in 1% NaOCl for 2 min, rinsed with sterilized distilled water for 5 min, and placed onto plum extract agar. Cultures were incubated in the dark at 22°C for 7 to 14 days. The resultant colonies (three to four per location) were subcultured and identified putatively as a Verticillium sp. closely related to Verticillium albo-atrum Reinke and Berthold (3), based on melanized, thick-walled, resting mycelia and phialides arranged in verticillate whorls that amassed round, oval-shaped conidia (5.1 ± 1.2 µm × 2.8 ± 0.4 µm, n = 100). Molecular identification of two fungal isolates (one per location) was determined by amplification of the protein coding genes elongation factor 1-alpha (EF), glyceraldehyde-3-phosphate dehydrogenase (GPD), and tryptophan synthase (TS), using PCR primers developed recently for Verticillium (3). A BLAST search on the edited contigs revealed 100% sequence similarity for all three protein coding genes among the two isolates and reference sequences of isolates PD592 (GenBank Accessions JN188227, JN188163, and JN188035 for EF, GPD, and TS, respectively) and VnAaPA140 (KC307764, KC307766, and KC307768 for EF, GPD, and TS, respectively) of the newly-proposed species, V. nonalfalfae (formerly V. albo-atrum). Aligned sequences from one representative isolate, VnAaVA2 (Bedford Co.), were deposited into GenBank as KC307758 (EF), KC307759 (GPD), and KC307760 (TS). To confirm pathogenicity to A. altissima, the two molecularly characterized isolates (one per location) were inoculated into 18 10-week old A. altissima stems that were grown in an environmental chamber at 24°C, 60% RH, and a 12-h photoperiod from seeds collected in Blacksburg, VA. A conidial suspension of each isolate was injected into each stem (0.1 ml of 1 × 108 CFU/ml/stem). All 36 seedlings inoculated with the proposed V. nonalfalfae isolates developed wilting of leaflets within 2 weeks post-inoculation (WPI), defoliation of leaflets by 6 WPI, and were dead by 9 WPI. Eighteen control seedlings were inoculated similarly with distilled water, and remained asymptomatic. Fungi resembling the proposed species V. nonalfalfae were reisolated from all inoculated stems except the control plants, and the species confirmed morphologically as described above. V. nonalfalfae is a recently proposed species that can infect a variety of plant species (3). To our knowledge, this is the first report of this proposed species on A. altissima in Virginia. New state reports of this pathogen on A. altissima are important for regulatory issues associated with using this pathogen as a potential biological control agent. References: (1) G. F. Gravatt and R. B. Clapper. Plant Dis. Rep. 16:96, 1932. (2) M. J. Schall and D. D. Davis. Plant Dis. 93:747, 2009. (3) P. Inderbitzin et al. PLoS ONE, 6, e28341, 2011.

16.
Public Health Genomics ; 15(1): 22-30, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-21654153

RESUMEN

BACKGROUND/AIMS: To predict the potential public health impact of personal genomics, empirical research on public perceptions of these services is needed. In this study, 'early adopters' of personal genomics were surveyed to assess their motivations, perceptions and intentions. METHODS: Participants were recruited from everyone who registered to attend an enrollment event for the Coriell Personalized Medicine Collaborative, a United States-based (Camden, N.J.) research study of the utility of personalized medicine, between March 31, 2009 and April 1, 2010 (n = 369). Participants completed an Internet-based survey about their motivations, awareness of personalized medicine, perceptions of study risks and benefits, and intentions to share results with health care providers. RESULTS: Respondents were motivated to participate for their own curiosity and to find out their disease risk to improve their health. Fewer than 10% expressed deterministic perspectives about genetic risk, but 32% had misperceptions about the research study or personal genomic testing. Most respondents perceived the study to have health-related benefits. Nearly all (92%) intended to share their results with physicians, primarily to request specific medical recommendations. CONCLUSION: Early adopters of personal genomics are prospectively enthusiastic about using genomic profiling information to improve their health, in close consultation with their physicians. This suggests that early users (i.e. through direct-to-consumer companies or research) may follow up with the health care system. Further research should address whether intentions to seek care match actual behaviors.


Asunto(s)
Participación de la Comunidad , Predisposición Genética a la Enfermedad , Genómica , Motivación , Percepción , Medicina de Precisión , Adolescente , Adulto , Anciano , Femenino , Humanos , Difusión de la Información , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Adulto Joven
17.
J Nematol ; 44(4): 316-20, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23482428

RESUMEN

Previously we showed in laboratory studies that the fungivorus nematode, Aphelenchoides hylurgi, was attracted to and fed upon the chestnut blight fungus, Cryphonectria parasitica, from American chestnut bark cankers and was a carrier of biocontrol, white hypovirulent C. parasitica strains. In the present field study, we recovered Aphelenchoides spp. in almost all (97.0 %) of 133 blight canker tissue assays (three 5-g samples each) from four eastern states. High mean population densities (227 to 474 nematodes per 5 g tissue) of Aphelenchoides spp. were recovered from cankers in Virginia, West Virginia, and Tennessee but not from New Hampshire (mean = 75 nematodes per 5 g tissue). Overall, most canker assays yielded population densities less than 200 nematodes per 5 g tissue. All of 12 very small or young cankers yielded a few to many Aphelenchoides spp. Regression analysis indicated greatest recovery of Aphelenchoides spp. occurred in the month of May (r = 0.94). The results indicate that Aphelenchoides spp. appear to be widespread in blight cankers on American chestnut trees and could play a role in biocontrol of chestnut blight.

18.
Bioresour Technol ; 102(17): 8199-204, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21680181

RESUMEN

Experiments were conducted by thermal gravimetric analysis (TGA) and cone calorimetry to measure the affect of three fire retardants (ammonium sulphate, boric acid and borax) on the mass-loss rate and combustion characteristics of sugar-cane bagasse. Compared with untreated bagasse, bagasse impregnated with aqueous solutions of 0.1-0.5M fire retardants exhibited an increase in char mass production from 16% up to 41% when pyrolysed and up to a 41% reduction in total heat release (THR) during combustion. Char mass production was only a weak function of additive concentration over the range of concentrations (0.1-0.5M) used. Combining the additives did not show any synergistic effects for char production or heat release rate (HRR). Treatment of bagasse by these chemicals could be useful to enhance biochar yields in pyrolysis processes or to reduce flammability risk in composites containing bagasse.


Asunto(s)
Retardadores de Llama , Calor , Saccharum/química , Cinética , Nitrógeno/química
19.
J Neuroendocrinol ; 23(6): 465-71, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21518031

RESUMEN

The ventromedial nucleus of the hypothalamus (VMH) is a major site for the control of female sexual behaviour by ovarian steroid hormones. This review explores recent details that have emerged regarding the ovarian hormone-induced remodelling of neural circuits within the VMH in adult female rats, with the goal of refining the model of the VMH neural circuit. VMH neurones exhibit simple dendritic arbours, with a single long primary dendrite (LPD) and several short primary dendrites. We recently found that ovarian hormones have unanticipated differential effects on the length of the LPDs, suggesting an intricate synaptic reorganisation. LPDs extend into the lateral fibre plexus where they contact oxytocin-labelled terminals. Oestradiol treatment rearranges this oxytocin innervation, in particular by withdrawing some of the LPDs and intensifying the oxytocin input to the remaining dendrites. These changes are reversed with concomitant progesterone treatment. Incorporating these new results, we have updated our working model of hormone-induced synaptic reorganisation in the VMH, emphasising the rebalancing of local versus extrinsic connectivity. The new working model synthesises the recent evidence for rewiring with insights from electrophysiological and behavioural pharmacological studies that pertain to the roles of oxytocin and glutamate in VMH neural activity and mating behaviour.


Asunto(s)
Hormonas Gonadales/farmacología , Plasticidad Neuronal/efectos de los fármacos , Ovario/metabolismo , Reproducción/efectos de los fármacos , Núcleo Hipotalámico Ventromedial/efectos de los fármacos , Factores de Edad , Animales , Femenino , Hormonas Gonadales/metabolismo , Hormonas Gonadales/fisiología , Modelos Biológicos , Plasticidad Neuronal/fisiología , Ratas , Reproducción/fisiología , Núcleo Hipotalámico Ventromedial/metabolismo , Núcleo Hipotalámico Ventromedial/fisiología
20.
Artículo en Inglés | MEDLINE | ID: mdl-22254921

RESUMEN

The arrhythmogenic substrate in patients with prior myocardial infarct (MI) is located at the border zone, BZ. In this study we correlated the BZ identified by two methods: electro-anatomical voltage mapping (EAVM) and a novel MRI method, multi-contrast late enhancement (MCLE). A pre-clinical porcine model with chronic MI was used to characterize BZ via MRI and EAVM. Results focus on the comparison between scar percentage and BZ percentage identified by each method. The correlation coefficient for BZ percentage between the two methods was 0.74 with a p-value of less the 0.0001. Bland-Altman plots were also used to compare between the two methods (slope of 0.83 ± 0.045). For a case of subtle infarct, there was only 1.3% infarct identified on EAVM compared to 22.2% on the corresponding slice on MCLE. The percentage of infarct on MCLE in subtle infarct does not relate to percentage of infarct in EAVM. Future registration between T(1) maps and EAVM will permit a quantitative comparison of MRI and EAVM measures.


Asunto(s)
Modelos Animales de Enfermedad , Imagen por Resonancia Magnética/métodos , Infarto del Miocardio/fisiopatología , Animales , Infarto del Miocardio/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...